Brinter
Modular bioprinting platform for research, personalized medicine, and space applications
- CEO / Founder
- Tomi Kalpio
- Team Size
- 10-20
- Stage
- Seed
- Total Funding
- €1.2M
- Latest Round
- Seed
- Key Investors
- Innovestor
Technology & Products
Key Products
Brinter Core bioprinter, multi-material bioprinting tools, space-adapted bioprinter
Technological Advantage
Modular platform enabling multiple bioprinting modalities in one system
Differentiation
Value Proposition
Multi-material, multi-fluidic bioprinting for flexible tissue engineering
How They Differentiate
Modular multi-material approach and space bioprinting capability
Market & Competition
Target Customers
Research institutions, pharmaceutical companies, hospitals
Industry Verticals
Biotechnology, Pharmaceuticals, Research, Healthcare, Space
Competitors
CELLINK, Organovo, Aspect Biosystems
Growth & Milestones
Growth Metrics
Active in 10+ countries including Germany and UK
Major Milestones
2019: Founded as 3DTech, 2020: Launched Brinter brand, 2021: €1.2M seed funding, 2024: Space bioprinter project announced
Notable Customers
Research institutions, pharmaceutical companies